Cystogram Before Removal of Foley Catheter After Repair of Colovesical Fistula
Cystogram for Early Foley Catheter Removal Post Colovesical Fistula Resection
1 other identifier
observational
24
1 country
1
Brief Summary
Colovesical fistulas are well-recognized but relatively uncommon pathology to both the general and colorectal surgeon. It is a complication arising from an underlying primary acute to chronic inflammatory process. Although colovesical fistulas are uncommon, they are associated with significant morbidity, affect quality of life, and may lead to death, usually secondary to urosepsis. Early diagnosis and management is essential. The purpose of the study is to determine the objective use of cystographic evaluation on postoperative day two to guide early Foley catheter removal post colovesical fistula takedown. The hypothesis is that a cystogram showing no extravasation of contrast on postoperative day two will predict safe removal without increased morbidity. This is an uncontrolled, single arm trial. Patients who meet criteria to undergo either minimally invasive or open colovesical fistula takedown with sigmoid colectomy, without evidence of the need for bladder repair will be eligible to participate. An indwelling Foley catheter is placed intraoperative and continued postoperative. All patients who consent to participate would undergo a cystogram on postoperative day two. The cystogram will be conducted by a radiologist and technician well-trained in the techniques and interpretation of the study. The colorectal surgery enhanced recovery protocol will be followed on all patients with the exception of the cystogram being conducted on post-op day two. If there is no evidence of extravasation of dye is seen on the cystogram the Foley catheter will be removed. Patients will be monitored closely following catheter removal to ensure self-diuresis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2017
CompletedFirst Submitted
Initial submission to the registry
May 3, 2018
CompletedFirst Posted
Study publicly available on registry
May 16, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 18, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 18, 2022
CompletedOctober 25, 2023
October 1, 2023
4.9 years
May 3, 2018
October 24, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Successful Foley Catheter Removal at Day 2
Defined as no evidence of extravasation of dye is seen on the cystogram on day two, followed by successful self diuresis within 16 hours of Foley catheter removal.
16 Hours After Foley Catheter Removal
Study Arms (1)
Cystogram on Post-Op Day 2
An indwelling Foley catheter is placed intraoperative and continued postoperative. All patients who consent to participate would undergo a cystogram on postoperative day two. The cystogram will be conducted by a radiologist and technician well-trained in the techniques and interpretation of the study. The colorectal surgery enhanced recovery protocol will be followed on all patients with the exception of the cystogram being conducted on post-op day two.
Eligibility Criteria
Patients meeting all inclusion and no exclusion criteria being cared for at Mount Carmel Health System
You may qualify if:
- adult patients with clinical, radiographic, or endoscopic confirmation of a colovesical fistula
- patients undergoing either minimally invasive or open colovesical fistula takedown with sigmoid colectomy, without evidence of the need for bladder repair
You may not qualify if:
- malignant disease
- Crohn's disease
- radiation-induced colovesical fistula
- current pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mount Carmel Health System
Columbus, Ohio, 43213, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jaswant Madhavan, MD
Mount Carmel Health System
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 3, 2018
First Posted
May 16, 2018
Study Start
December 1, 2017
Primary Completion
October 18, 2022
Study Completion
October 18, 2022
Last Updated
October 25, 2023
Record last verified: 2023-10